Which medicines is Lenvatinib Eisai combined with for advanced renal cell carcinoma, and in which treatment settings?

For adults with advanced renal cell carcinoma, Lenvatinib Eisai is combined with pembrolizumab as first-line treatment or with everolimus following one prior vascular endothelial growth factor (VEGF)-targeted therapy.